Inventor · disambiguated record
Matthew Linnik
Also filed as: LINNIK MATTHEW D · LINNIK MATTHEW DAVID
3 granted patents·22 pending applications·83 citations·filing 1995–2024
74Inventor score
Top patents by PatentIndex Score
25 records- 0176US5691368ASubstituted oxazolidine calpain and/or cathepsin B inhibitorsHOECHST MARION ROUSSEL INC·Filed 1995·Granted Nov 25, 1997·41 cites·16 claims
- 0274US6858210B1Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using sameJOLLA PHARMA·Filed 1999·Granted Feb 22, 2005·33 cites·104 claims
- 0373US7081242B1Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereofJOLLA PHARMA·Filed 2000·Granted Jul 25, 2006·9 cites·64 claims
- 0473US2024398973A1Engineered antibody compounds and conjugates thereofLILLY CO ELI·Filed 2024·Application pending·0 cites
- 0558US2007191297A1Methods of treating and monitoring systemic lupus erythematosus in individualsLINNIK MATTHEW D·Filed 2006·Application pending·0 cites
- 0658US2007179111A1Methods of treating proteinuria by reducing double-stranded dna antibodiesLINNIK MATTHEW D·Filed 2006·Application pending·0 cites
- 0757US2006229270A1Methods of treating proteinuria by reducing double-stranded DNA antibodiesJOLLA PHARMA·Filed 2006·Application pending·0 cites
- 0857US2007218072A1Methods of improving health-related quality of life in individuals with systemic lupus erythematosusSTRAND VIBEKE·Filed 2006·Application pending·0 cites
- 0956US2020155702A1Engineered Antibody Compounds and Conjuates ThereofLILLY CO ELI·Filed 2018·Application pending·0 cites
- 1054US2004258683A1Methods of treating and monitoring systemic lupus erythematosus in individualsFiled 2004·Application pending·0 cites
- 1153US2009203764A1Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseasesWANG ERIC YANJUN·Filed 2009·Application pending·0 cites
- 1253US2024285787A1Peptides comprising n-formyl-halogenated methionine residues and engineered antibody-peptide conjugates thereofLILLY CO ELI·Filed 2022·Application pending·0 cites
- 1353US2004208864A1Methods of improving health-related quality of life in individuals with systemic lupus erythematosusFiled 2003·Application pending·0 cites
- 1450US2010152281A1Methods of treating systemic lupus erythematosus in individuals having significantly impaired renal functionLINNIK MATTHEW D·Filed 2008·Application pending·0 cites
- 1549US2005004351A1Therapeutic and diagnostic domain 1 beta2GP1 polypeptides and methods of using sameFiled 2004·Application pending·0 cites
- 1648US2007293548A1Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseasesWANG ERIC Y·Filed 2007·Application pending·0 cites
- 1745US2006142229A1Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereofJOLLA PHARMA·Filed 2005·Application pending·0 cites
- 1843US2006217333A1Methods of treating systemic lupus erythematosus in individuals having significantly impaired renal functionLINNIK MATTHEW D·Filed 2006·Application pending·0 cites
- 1941US2003077273A1Methods of treating antibody-mediated pathologies using agents which inhibit CD21Filed 2002·Application pending·0 cites
- 2041US2005096360A1Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment of diseasesFiled 2004·Application pending·0 cites
- 2140US2011269811A1Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseasesWANG ERIC YANJUN·Filed 2011·Application pending·0 cites
- 2239US2003114405A1Methods of treating systemic lupus erythematosus in individuals having significantly impaired renal functionFiled 2002·Application pending·0 cites
- 2335US2018201673A1Treatment of pruritusLILLY CO ELI·Filed 2016·Application pending·0 cites
- 2432US2003159159A1Human nerve growth factor exon 1 and exon 3 promotersFiled 2001·Application pending·0 cites
- 2517US2003192065A1Human nerve growth factor exon 1 and exon 3 promotersFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew Linnik files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →